SPARC announces submission of IND application for SBO-154 to USFDA EP News Bureau Mar 31, 2025 SBO-154 set to enter global Phase 1 clinical trial for treatment of advanced solid tumours
Epygenix Therapeutics announces FDA acceptance of IND to initiate clinical trial of EPX-100 to treat… EP News Bureau Aug 31, 2021 Lennox-Gastaut Syndrome (LGS) is a rare epileptic encephalopathy presenting in childhood with intractable seizures. Approximately…
CSIR’s anti-cancer drug IIIM-290 goes into clinical trial Press Information Bureau Jun 9, 2020 The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy…
